not tagged
boehringer ingelheim
['boehringer']
researcher is presenting phase 1 data for our investigational mdm@-p53 antagonist. #esmo22.
Official US Twitter channel for Boehringer Ingelheim, tweeting company news and related health info. Outside the US? Please follow @boehringer.